As a possible molecular pathomechanism for anemia in low-risk MDS, a pro-apoptotic niche with increased activity of apoptosis-promoting factors such as tumor necrosis factor (TNFα) and pro-apoptotic Fas ligand (CD95L) have been proposed [4–8]. The gene discussed is TNF; the disease is myelodysplastic syndrome.